pomalidomide has been researched along with tfc 007 in 2 studies
| Studies (pomalidomide) | Trials (pomalidomide) | Recent Studies (post-2010) (pomalidomide) | Studies (tfc 007) | Trials (tfc 007) | Recent Studies (post-2010) (tfc 007) |
|---|---|---|---|---|---|
| 623 | 121 | 552 | 7 | 0 | 7 |
| Protein | Taxonomy | pomalidomide (IC50) | tfc 007 (IC50) |
|---|---|---|---|
| Hematopoietic prostaglandin D synthase | Homo sapiens (human) | 0.171 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aritake, K; Demizu, Y; Fujii, K; Ito, T; Murakami, Y; Naganuma, M; Naito, M; Shibata, N; Yokoo, H | 1 |
| Aritake, K; Demizu, Y; Endo, A; Fujii, K; Hamamura, K; Ito, T; Murakami, Y; Naito, M; Saeki, Y; Shibata, N; Yanase, Y; Yokoo, H | 1 |
2 other study(ies) available for pomalidomide and tfc 007
| Article | Year |
|---|---|
Development of a Hematopoietic Prostaglandin D Synthase-Degradation Inducer.
Topics: | 2021 |
Discovery of a Highly Potent and Selective Degrader Targeting Hematopoietic Prostaglandin D Synthase via In Silico Design.
Topics: Animals; Bone Marrow; Cardiomegaly; Cell Line, Tumor; Computer Simulation; Drug Discovery; Enzyme Inhibitors; Humans; Intramolecular Oxidoreductases; Ligands; Lipocalins; Male; Mice; Mice, Inbred mdx; Molecular Docking Simulation; Muscular Dystrophy, Duchenne; Proteolysis | 2021 |